BFC Planning’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231 Hold
18
– – ﹤0.01% 3343
2026
Q2
$178 Hold
18
– – ﹤0.01% 3330
2026
Q1
$110 Hold
18
– – ﹤0.01% 2960
2025
Q4
$150 Sell
18
-1,378
-99% -$14.8K ﹤0.01% 3048
2025
Q3
$20.4K Hold
1,396
– – ﹤0.01% 1572
2025
Q2
$15.7K Buy
1,396
+1,378
+7,656% +$10.7K ﹤0.01% 1607
2025
Q1
$103 Sell
18
-12
-40% -$122 ﹤0.01% 2611
2024
Q4
$295 Hold
30
– – ﹤0.01% 2510
2024
Q3
$245 Buy
+30
New +$301 ﹤0.01% 2512

Other funds holding DNA

BFC Planning's DNA Position: Q3 2026 in Review

BFC Planning held its Ginkgo Bioworks (DNA) position steady in Q3 2026 at 18 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #3343.

BFC Planning first reported a position in DNA in Q3 2024 and has held it in 9 quarters since. The position peaked at $20.4K in Q3 2025. 128 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • BFC Planning held 18 shares of Ginkgo Bioworks worth $231 as of Q3 2026.
  • BFC Planning left its Ginkgo Bioworks share count unchanged in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3343 holding.
  • BFC Planning first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Ginkgo Bioworks position peaked at $20.4K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.